Skip to main content

Genomics One to Sell $538K Worth of Assets to Medicorp

NEW YORK, May 27 (GenomeWeb News) - Laval, Quebec-based Genomics One will sell about CA$677,330 ($538,204) worth of assets from its BioCan Scientific subsidiaries in Canadaand the USto Montreal-based Medicorp.

 

The closing of the sale is planned for March 31, at which time Medicorp will pay CA$500,000, leaving a balance of CA$177,300, which will be held in escrow for 90 days.

 

According to Genomics One, the pending sale will help the company to focus on entering into the biodefense market using mass spectrometry technology.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.